Prisma Health oncologist Dr. Ki Chung says since Brooks had stage four colorectal cancer, it had spread to her liver. The HAI ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...

A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an ...

A new research paper was published in Volume 16 of Oncotarget on July 21, 2025, titled “Statins exhibit anti-tumor potential ...

Colorectal cancer is the third most common cancer worldwide. It is estimated that there are over 1.5 million diagnoses a year ...

Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and ...

NG-350A has received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a significant unmet medical need. The drug is an intravenously delivered ...

Lynch Syndrome (LS) is a common hereditary condition that greatly increases lifetime risk of colorectal, endometrial, urothelial and other ...

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...

A new mechanism explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer.

Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...